EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis

Moumen M Alhasan, Oliver Hölsken, Claudia Duerr, Sofia Helfrich iD, Nora Branzk, Alina Philipp, Dominik Leitz, Julia Duerr iD, Yahia Almousa iD, Gabriela Barrientos, William W Mohn, Stefanie Gamradt und 1 weitere

European Journal of Immunology · 2023

DOI: 10.1002/eji.202350394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Moumen M Alhasan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humb…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Asthma. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Konrad-Adenauer-Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic use during pregnancy is associated with increased asthma risk in children. Since approximately 25% of women use antibiotics during pregnancy, it is important to identify the pathways involved in this phenomenon. We investigate how mother‐to‐offspring transfer of antibiotic‐induced gut microbial dysbiosis influences immune system development along the gut–lung axis. Using a mouse model of maternal antibiotic exposure during pregnancy, we immunophenotyped offspring in early life and after asthma induction. In early life, prenatal‐antibiotic exposed offspring exhibited gut microbial dysbiosis, intestinal inflammation (increased fecal lipocalin‐2 and IgA), and dysregulated intestinal ILC3 subtypes. Intestinal barrier dysfunction in the offspring was indicated by a FITC‐dextran intestinal permeability assay and circulating lipopolysaccharide. This was accompanied by increased T‐helper (Th)17 cell percentages in the offspring's blood and lungs in both early life and after allergy induction. Lung tissue additionally showed increased percentages of RORγt T‐regulatory (Treg) cells at both time points. Our investigation of the gut–lung axis identifies early‐life gut dysbiosis, intestinal inflammation, and barrier dysfunction as a possible developmental programming event promoting increased expression of RORγt in blood and lung CD4 + T cells that may contribute to increased asthma risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAsthmaPregnancyChildHumansFemaleAnti-Bacterial AgentsNuclear Receptor Subfamily 1, Group F, Member 3DysbiosisInflammationLung

Stichwörter der Autor:innen

Th17 cellantibioticsasthmagut-lung axispregnancy

Substanzen

Anti-Bacterial AgentsNuclear Receptor Subfamily 1, Group F, Member 3

Autor:innen und Institutionen

  • Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, German…
  • Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Anesthesiology and Intensive Care Medicine, Charité Campus Benjamin Franklin, Berlin, Ge…
  • German Rheuma Research Center Berlin (DRFZ), Mucosal and Developmental Immunology, Berlin, Germany.
  • Heidelberg Biosciences International Graduate School (HBIGS), Heidelberg University, Heidelberg, Germany.
  • Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, B…
  • Laboratory of Molecular Tumor Pathology, Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin,…

ORCID-Profile: Sofia Helfrich, Julia Duerr, Yahia Almousa

Förderung

  • Deutsche Forschungsgemeinschaft
  • Konrad-Adenauer-Stiftung

Zitieren

APA

Alhasan, M. M., Hölsken, O., Duerr, C., Helfrich, S., Branzk, N., Philipp, A., Leitz, D., Duerr, J., Almousa, Y., Barrientos, G., Mohn, W. W., Gamradt, S., & Conrad, M. L. (2023). Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis. European Journal of Immunology. https://doi.org/10.1002/eji.202350394

Vancouver

Alhasan MM, Hölsken O, Duerr C, Helfrich S, Branzk N, Philipp A, et al. Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis. European Journal of Immunology. 2023. doi:10.1002/eji.202350394

BibTeX
@article{Alhasan2023,
  author = {Alhasan, Moumen M and Hölsken, Oliver and Duerr, Claudia and Helfrich, Sofia and Branzk, Nora and Philipp, Alina and Leitz, Dominik and Duerr, Julia and Almousa, Yahia and Barrientos, Gabriela and Mohn, William W and Gamradt, Stefanie and Conrad, Melanie L},
  title = {Antibiotic use during pregnancy is linked to offspring gut microbial dysbiosis, barrier disruption, and altered immunity along the gut–lung axis},
  journal = {European Journal of Immunology},
  year = {2023},
  doi = {10.1002/eji.202350394}
}
Kostenlos starten →